Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common inherited disorder that predominantly manifests with the formation of ß uid-Þ lled cysts in both kidneys. The disease can be accounted for by a mutation in either the PKD1 or the PKD2 gene. We have previously demonstrated that aberrant expression of the PKD1 gene product, polycystin-1, results in modiÞ cation of Activator Protein-1 (AP-1) transcription factor activity in cultured renal epithelial cells. Here, we report that activity of the AP-1 components c-Jun, ATF2, and c-Fos is altered in renal cystic tissue of human ADPKD patients and of hypomorphic Pkd1 mice with polycystic kidney disease. Data were obtained using immunohistochemical and western blot analysis. SigniÞ cant up-regulation of Thr71-and Thr69/71-phosphorylated ATF2, and Ser73-phosphorylated c-Jun, and increased c-Fos were detected in small cysts and (dilated) ducts and tubules surrounded by Þ brotic interstitium. Our data indicate that various AP-1 components are constitutively activated in polycystic kidney disease and suggest that aberrant AP-1 activity is relevant for cyst formation.
Introduction
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common inherited disorder that predominantly manifests with progressive development of ß uid-Þ lled cysts in both kidneys. Cyst formation ultimately results in chronic renal failure. In the majority of patients, the disease can be accounted for by a mutation in the PKD1 gene (1, 2) , while a minority suff ers from a mutation in the PKD2 gene (3) (4) (5) . Several studies have implicated a role for the PKD1 gene product, polycystin-1, in signal transduction pathways governing Activator Protein-1 activity (AP-1; 6-8). Moreover, we have reported that AP-1 activity is aberrant in an immortalized renal cystic epithelial cell line derived from a patient with ADPKD (8) . AP-1 transcription factors are composed of multiple homo-or heterodimers that regulate key cellular processes such as cell proliferation, diff erentiation, and survival (9) (10) (11) . The heterogeneity of AP-1 is thought to provide a mechanism to regulate a broad spectrum of cellular responses, since AP-1 can be activated by a variety of stimuli, such as growth factors and genotoxic stress. These stimuli aff ect intracellular signaling pathways resulting in activation of one or more AP-1 components including Jun, ATF, and Fos family members. Both the activity and expression levels of these transcription factors can be regulated by Mitogen Activated Protein Kinases (MAPKs), including Extra-cellular signal-Regulated Kinase (ERK), p38, and c-Jun N-terminal kinase (JNK; 12). Phosphorylation of c-Jun at Ser73 results in increased transactivation potential and stability. Transactivation capacity of ATF2 is regulated via phosphorylation at Thr71 and Thr69 (13) . To further elucidate the role of AP-1 in ADPKD cystogenesis, we analyzed various AP-1 components in human and mouse ADPKD renal cystic tissue using immunohistochemical and western blot analysis. Here, we report that Thr71-and Thr69/71-phosphorylated ATF2, Ser73-phosphorylated c-Jun, and also c-Fos are increased in small cysts and (dilated) ducts and tubules surrounded by Þ brotic interstitium. Our data indicate that AP-1 activity is up-regulated in human and mouse polycystic kidneys, suggesting that renal cyst formation and accompanying interstitial Þ brosis may in part result from changes in AP-1 activity.
Materials and Methods

Human tissue samples of normal and cystic kidneys
Renal tissue from ADPKD patients with chronic renal failure was Þ xed in 4% formalin and embedded in paraffi n as described (14) . Control renal tissue was isolated from donor kidneys intended for transplantation, but not suitable due to technical reasons (i.e. branching of the renal artery). In total three human control renal tissue samples (ET10, ET13, and ET14) and six human ADPKD renal cystic tissue samples of patients with known mutations in or positive linkage to PKD1 were analyzed (Table 1) .
Mouse tissue samples of normal and cystic kidneys
Renal cystic tissue was isolated from a mouse model with hypomorphic Pkd1 alleles due to the presence of a neomycin resistance marker in intron 1 (Pkd1 nl/nl ; 17). These mice develop polycystic kidney disease comparable to human ADPKD with the majority of cysts originating from collecting ducts. Healthy wild-type age-matched mice were used as controls. Animal experiments were performed with approval of the animal experimentation committ ee of the Leiden University Medical Center according to the animal experimentation guideline of the Dutch government.
Antibodies and reagents for immunohistochemistry
Dolichos Biß orus agglutinin-HRP conjugate was diluted 1:50 for immunohistochemistry (Sigma, Zwĳ ndrecht, The Netherlands), rabbit antiaquaporin-2 1:300 (Calbiochem, Amsterdam, The Netherlands), goat antiuromodulin 1:5000 (Organon Teknika-Cappel, Turnhout, Belgium), and rabbit anti-megalin 1:500 (18, 19) . Rabbit-anti-phospho-Thr71-ATF2 was diluted 1:50, rabbit-anti-phospho-Thr69/71-ATF2 1:50, and rabbit-anti-phospho-Ser73-c-Jun 
Immunohistochemical analysis
Renal tissue sections were stained with nephron segment-speciÞ c markers (19) . Dolichos Biß orus agglutinin (DBA) is expressed in collecting duct and, to a lesser extent, in distal tubules. Aquaporin-2 is also expressed in collecting ducts, whereas uromodulin is present in distal tubules and thick ascending limbs of Henle's loop. Megalin is expressed in proximal tubules. Histochemical staining was performed as described (19) . For ATF2, c-Jun, c-Fos, and polycystin-1 tissue sections were stained using the following protocol. Sections were de-paraffi nised and washed with PBS for 5 minutes. Antigen retrieval was performed for ATF2, c-Jun, and c-Fos by boiling in 10 mM citrate buff er at pH 6 for 10 minutes followed by cooling for 20 minutes. Sections were then washed three times with demi water. Each wash step was carried out for 5 minutes. Blocking for endogenous peroxidase activity was performed in 1% H 2 O 2 for 20 minutes. Sections were washed three times with demi water followed by washing with PBS. Sections were then pre-incubated with 5% normal goat serum in PBS for one hour. Incubation with primary antibodies for Thr71-phosphorylated ATF2, Thr69/71-phosphorylated ATF2, Ser73-phosphorylated c-Jun, total c-Fos, and polycystin-1, was done overnight at 4°C. Aft er washing three times with PBS, sections were incubated with rabbit Envision-HRP for 30 minutes, washed three times with PBS, developed using DAB with 0.7% NiCl 2 for 10 minutes (black/brown precipitate). For mouse tissue sections, PKS-A was incubated with mouse Envision-HRP overnight at 4°C. The next day, blocking reagent from the ARK kit was added (Dako). Sections were then incubated with the PKS-A-HRP conjugated antibody for one hour and developed as described. For Sirius red staining of the interstitial component collagen, sections were incubated in 0.2% phosphormolybdenic acid for 5 minutes and then in 0.1% Sirius red in picrinic acid for 15 minutes. All sections were counterstained with hematoxylin (blue), with the exception of sections stained for ATF2, c-Jun, and c-Fos. Sections were analyzed using a Leica DM-LB light microscope (Leica, Rĳ swĳ k, The Netherlands). Digital images were taken at 200x magniÞ cation using Leica DC500 digital camera and soft ware.
Western blot analysis
Tissue samples were homogenized in RIPA buff er (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% DOC, 1% TX-100, 1% NP-40) supplemented with complete protease inhibitor cocktail (Roche B.V., Almere, The Netherlands), 0.5 µM sodium-ß uoride, and 0.5 µM sodium-vanadate (Sigma) using a mortle and pestle and MagNa Lyzer (Roche). Western blot analysis was performed as described (8) . Rabbit-anti-phospho-Thr71-ATF2, rabbit-anti-phospho-Thr69/71-ATF2, and rabbitanti-phospho-Ser73-c-Jun were diluted 1:500, rabbit anti-c-Fos 1:1000 (Upstate, Charlott esville, VA, USA), and mouse anti-β-actin 1:40000 (MP Biomedicals, Amsterdam, The Netherlands). Primary antibodies were detected using goatanti-rabbit-HRPO 1:10000 (Jackson ImmunoResearch Laboratories Inc.) or sheepanti-mouse-HRPO conjugate 1:10000 (Amersham Biosciences, Roosendaal, The Netherlands). Proteins were detected using enhanced chemiluminescence (Sigma) on Kodak BioMax Light Film (Kodak, Roosendaal, The Netherlands). Expression was quantiÞ ed using densitometry and expressed relatively to the loading control β-actin. Statistical analysis was performed using the student's t-test.
Results
Expression of ATF2, c-Jun, c-Fos, and polycystin-1 in normal human renal tissue
We analyzed AP-1 activity in three human normal renal tissue samples (Table 1) . To distinguish between diff erent nephron segments, markers were included for immunohistochemical analysis. DBA and aquaporin-2 both served as markers for collecting ducts and showed similar expression patt erns (Figure 1 ). Uromodulin was used as a marker for distal tubules and megalin for proximal tubules. Normal human renal tissue showed coordinate expression of active Thr71-and Thr69/71-phosphorylated ATF2, Ser73-phosporylated c-Jun, c-Fos, and polycystin-1 in collecting ducts and distal tubules ( Figure 1 ; Table 2 ). Expression of polycystin-1 in collecting ducts and distal tubules was reported previously (14, 20, 21) . Expression was also detected in the parietal epithelial cells of Bowman's capsule, in vascular structures, and in the multi-layer cubical epithelium of the papillary duct (data not shown). Sirius red staining indicates surrounding interstitium (Figure 1) .
Expression of ATF2, c-Jun, c-Fos, and polycystin-1 in human ADPKD renal cystic tissue
AP-1 activity was determined in six human renal cystic tissue samples (Table 1) . Small cysts and (dilated) ducts and tubules surrounded b y Þ brotic interstitium showed increased AP-1 activity. The level of Thr71-and Thr69/71 phosphorylated ATF2, Ser73-phosphorylated c-Jun, and c-Fos was elevated ( Figure 2 ; Table  2 ). Interestingly, polycystin-1 was coordinately detected and increased in these regions. Constitutive activity of AP-1 components may r e ß ect increased stress due to progressive development of cysts and interstitial Þ brosis. The expanded and Þ brotic interstitium surrounding the cysts, as detected by Sirius red staining, also In large cysts, levels of ATF2, c-Jun, c-Fos, and polycystin-1 were variable and generally lower than regions with small cysts. These large cysts mainly expressed markers for collecting ducts (data not shown). Some cyst-lining epithelial cells stained for multiple nephron segment markers, indicating that these cysts originated from multiple nephron segments or that these cyst-lining cells may have undergone de-diff erentiation and therefore lost nephron segment speciÞ c markers. To conÞ rm immunohistochemical data western blot analysis was performed on total renal tissue lysates ( Figure 3A ), since regions with small cysts, (dilated) ducts and tubules, and surrounding Þ brotic interstitium contribute to the majority of total renal tissue compared to large ß uid-Þ lled cysts which are relatively low in cell content. Expression levels were subsequently quantiÞ ed using densitometry and expressed relatively to the loading control β-actin ( Figure 3B ). Overall, total cystic tissue lysates also showed signiÞ cant increases in Thr71-and Thr69/71-phosphorylated ATF2, Ser73-phosphorylated c-Jun, and also c-Fos. Levels of phosphorylated ATF2 and c-Jun in cystic kidneys were signiÞ cantly increased when compared to total ATF2 and c-Jun protein levels ( Figure 3B ). These data indicate that indeed activity (ratio phosphorylated to total protein level) rather than expression (total protein level) of ATF2 and c-Jun is increased in renal cystic tissue. Noteworthy, both control and ADPKD cystic kidneys displayed some variations in AP-1 activity. This may be due to diff erences between individuals. Expression level of c-Jun in tissue sample PK131 was below detection threshold and could not be detected in the western blot depicted in Figure 3A . However, when this tissue sample was overloaded, increased Ser73-phosphorylated c-Jun was detected (data not shown). In summary, AP-1 activity was increased in small cysts and (dilated) ducts and tubules surrounded by Þ brotic interstitium. These cells displayed signiÞ cant elevation of nuclear Thr71-and Thr69/71-phosphorylated ATF2, Ser73-phosphorylated c-Jun, and also c-Fos.
Expression of ATF2, c-Jun, and c-Fos in normal and polycystic kidney tissue of the mouse
Thr71-phosphorylated ATF2 and Ser73-phosphorylated c-Jun expression in mouse control renal tissue was comparable to the patt ern observed in human renal control tissue (Figure 4) . However, Ser73-phosphorylated c-Jun was also detected in the cytoplasm of collecting duct epithelial cells. Cytoplasmic localization of c-Jun has been demonstrated previously (22) (23) (24) (25) . Expression of Thr69/71-phosphorylated ATF2 and c-Fos were not detected by immunohistochemistry in normal renal tissue. Renal cystic tissue from Pkd1 nl/nl mice suff ering from polycystic kidney disease showed similar alterations in AP-1 activity as observed in human ADPKD renal cystic tissues. Up-regulation of nuclear Thr71-phosphorylated ATF2 and Ser73-phosphorylated c-Jun in particular was a feature in kidneys with relatively small cysts ( Figure 5 ). Increases in Thr69/71-phosphorylated ATF2 and c-Fos were not as clear in mouse cystic tissue samples as in human samples. This may be due to slight species-speciÞ c diff erences between human and mouse. Interestingly, older mice that suff ered from more severe, progressive polycystic kidney disease showed more variable expression of ATF2, c-Jun, and c-Fos, comparable to the large cysts in human samples (data not shown). In summary, AP-1 is increased in both human (Figure 2 and Figure 3 ) and mouse renal cystic tissue samples analyzed ( Figure 5 ).
Discussion
Cyst formation in ADPKD ultimately leads to chronic renal failure. ADPKD patients with chronic renal failure represent 8-10% of all patients requiring renal dialysis and transplantation (26) . Therefore, further insight into the mechanism of ADPKD cyst formation is required. Several studies have linked MAPK signaling to cyst formation. Up-regulation of ERK has been reported previously in the Han:SPRD rat model for ADPKD and the bcl-2 -/-mouse model for cystic kidney disease (27, 28) . Increased activity of JNK has been recently reported in small cysts in another mouse model for polycystic kidney disease (29) . In addition, MAPK signaling has been demonstrated to play a major role in the uretic bud during kidney development (30, 31) . AP-1 is a major downstream target of MAPK signaling. Transactivation potential and expression of ATF2, c-Jun and c-Fos can be regulated by ERK, p38, and JNK family members. We, and others have previously reported that polycystin-1 can modulate AP-1 activity (6) (7) (8) . To further investigate the cellular defects in ADPKD cyst formation in vivo we analyzed AP-1 activity in renal cystic tissue isolated from human ADPKD patients and in renal cystic tissue from Pkd1 nl/nl mice with polycystic kidney disease. Interestingly, up-regulation of Thr71-and Thr69/71-phosphorylated ATF2, Ser73-phosphorylated c-Jun, and also c-Fos protein was detected in small cysts, (dilated) ducts and tubules representing initial stages of cyst formation (Figure 2 ). Increased c-Fos mRNA was reported previously in two animal models for polycystic kidney disease (32, 33) . Since cellular stress induces phosphorylation and activation of AP-1, our data indicate that these cells may be in an increased state of cellular stress due to progressive development of cysts and interstitial Þ brosis. Our data therefore suggest that AP-1 may play a role in ADPKD by promoting cyst formation and accompanying interstitial Þ brosis. Based on the observation that AP-1 activity was increased in small cysts, it can be speculated that constitutive AP-1 activity may play a role during early stages of cyst formation. However, to further study this hypothesis, cysts formation should be studied at earlier stages under more controlled laboratory conditions, for instance using conditional knockout mouse models for Pkd1 and Pkd2. The immortalized renal cystic epithelial cells analyzed in our previous report may represent a subset of end-stage cystic cells from large cysts displaying decreased level of Ser73-phosphorylated c-Jun and increased c-Fos in addition to an increase in Thr71-phosphorylated ATF2 (8) . Furthermore, cultured renal cystic cells may diff er from renal cystic epithelium since these cells are surrounded by an abundant expanded Þ brotic interstitium in vivo. The Þ brotic interstitium may contribute to aberrant AP-1 activity of renal cystic epithelium via extracellular matrix-toepithelium signaling. Interestingly, polycystin-1 was coordinately expressed and up-regulated with the AP-1 components in small cysts and (dilated) ducts and tubules. These data are in line with previous reports that increased polycystin-1 expression results in polycystic kidney disease (8, 34) . Renal epithelial cells expressing transgenic PKD1 show similar defects in AP-1 transcriptional activity as human ADPKD renal cystic epithelial cells (8) and transgenic Pkd1 mice develop polycystic kidney disease (34) . Increased Thr71-phosphorylation of ATF2, observed in both human and mouse ADPKD, may reß ect constitutive ERK activity (13) . Up-regulation of Ser73-phosphorylated c-Jun may reß ect constitutive JNK activity. We show here, to our knowledge, for the Þ rst time that AP-1 activity is increased in vivo in human and mouse polycystic kidney disease. Further experiments are required to investigate whether polycystins modulate AP-1 activity directly or via known AP-1 regulators, such as MAPKs, will provide further insight into the function of polycystins and the mechanism of cyst formation in ADPKD.
